Perivascular radiofrequency renal denervation lowers blood pressure and ameliorates cardiorenal fibrosis in spontaneously hypertensive rats.

Abstract

BACKGROUND:

Catheter-based renal denervation (RDN) is a promising approach to treat hypertension, but innervation patterns limit the response to endovascular RDN and the post-procedural renal artery narrowing or stenosis questions the endovascular ablation strategy. This study was performed to investigate the anti-hypertensive and target organ protective effects of perivascular RDN in spontaneously hypertensive rats (SHR).

METHODS:

SHR and normotensive Wistar-Kyoto (WKY) rats were divided into sham group (n = 10), radiofrequency ablation group (n = 20) in which rats received bilateral perivascular ablation with radiofrequency energy (2 watts), and chemical (10% phenol in 95% ethanol) ablation group (n = 12). The tail-cuff blood pressure was measured before the ablation and on day 14 and day 28 after the procedure. The plasma levels of creatinine, urea nitrogen, and catecholamines, urinary excretion of electrolytes and protein, and myocardial and glomerular fibrosis were analyzed and compared among the groups on day 28 after the procedure.

RESULTS:

We identified that 2-watt is the optimal radiofrequency power for perivascular RDN in rats. Perivascular radiofrequency and chemical ablation achieved roughly comparable blood pressure reduction in SHR but not in WKY on day 14 and day 28 following the procedure. Radiofrequency-mediated ablation substantially destroyed the renal nerves surrounding the renal arteries of both SHR and WKY without damaging the renal arteries and diminished the expression of tyrosine hydroxylase, the enzyme marker for postganglionic sympathetic nerves. Additionally, perivascular radiofrequency ablation also decreased the plasma catecholamines of SHR. Interestingly, both radiofrequency and chemical ablation decreased the myocardial and glomerular fibrosis of SHR, while neither increased the plasma creatinine and blood urea nitrogen nor affected the urinary excretion of electrolytes and protein when compared to sham group.

CONCLUSIONS:

Radiofrequency-mediated perivascular RDN may become a feasible procedure against hypertension, and provide similar anti-hypertensive and target organ protective effects as does the chemical ablation.

• Authors: Shujie Wei, Dan Li, Yan Zhang, Linan Su, Yunrong Zhang, Qiang Wang, Dachun Yang, De Li, Yongjian Yang, Shuangtao Ma
• Journal: PloS one (PLoS One) Vol. 12 Issue 4 Pg. e0176888 ( 2017) ISSN: 1932-6203 [Electronic] United States
• PMID: 28453557 (Publication Type: Journal Article)

Chemical References

• Catecholamines
• Sclerosing Solutions
• Phenol

Topics

• Animals
• Blood Pressure
• Catecholamines (blood)
• Catheter Ablation
• Denervation
• Fibrosis (drug therapy, pathology, surgery)
• Heart Diseases (drug therapy, pathology, surgery)
• Hypertension (drug therapy, pathology, physiopathology, surgery)
• Kidney (drug effects, innervation, pathology, physiopathology)
• Male
• Phenol (administration & dosage)
• Rats, Inbred SHR
• Rats, Inbred WKY
• Renal Artery (drug effects, innervation, pathology)
• Sclerosing Solutions (administration & dosage)
• Sympathetic Nervous System (pathology, physiopathology)